Page last updated: 2024-08-24

pazufloxacin and Infections, Legionella pneumophila

pazufloxacin has been researched along with Infections, Legionella pneumophila in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Araki, N; Izumikawa, K; Kakeya, H; Kamihira, S; Kohno, S; Morinaga, Y; Seki, M; Yamada, K; Yamada, Y; Yamamoto, Y; Yanagihara, K1
Bando, M; Ishii, Y; Ohno, S; Sugiyama, Y1
Furugen, M; Haranaga, S; Higa, F; Kawakami, K; Saito, A; Shinzato, T; Tateyama, M; Toyama, M1

Other Studies

3 other study(ies) available for pazufloxacin and Infections, Legionella pneumophila

ArticleYear
In vivo efficacy of sivelestat in combination with pazufloxacin against Legionella pneumonia.
    Experimental lung research, 2010, Volume: 36, Issue:8

    Topics: Animals; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Drug Therapy, Combination; Fluoroquinolones; Glycine; Legionella pneumophila; Legionnaires' Disease; Leukocyte Elastase; Longevity; Lung; Male; Mice; Mice, Inbred Strains; Oxazines; Serine Proteinase Inhibitors; Sulfonamides; Treatment Outcome

2010
[A travel abroad-associated case of Legionella pneumonia diagnosed by urinary antigen detection test].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2005, Volume: 79, Issue:4

    Topics: Aged; Anti-Bacterial Agents; Antigens, Bacterial; Clarithromycin; Drug Therapy, Combination; Fluoroquinolones; Humans; Immunologic Tests; Legionella pneumophila; Legionnaires' Disease; Male; Oxazines; Pneumonia, Bacterial; Travel; Turkey

2005
Efficacy of pazufloxacin mesilate in Legionnaires' disease: a case report and in vitro study of the isolate.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2005, Volume: 11, Issue:3

    Topics: Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Fluoroquinolones; Humans; Injections, Intravenous; Legionella pneumophila; Legionnaires' Disease; Male; Middle Aged; Oxazines; Treatment Outcome

2005